Companion Diagnostics
Companion diagnostics help identify which patients are most likely to benefit from a treatment. The value case usually depends on better targeting, avoided ineffective therapy, and clearer downstream cost and outcome consequences.
Our solutions can be applied to multiple disease areas. We currently focus on oncology, infection disease and neurology, but we are continuously expanding our portfolio.
Dedicated to the diagnosis, treatment, and research of cancer.
Caused by pathogens such as bacteria, viruses, fungi, and parasites.
Focused on diagnosing and treating disorders of the nervous system
Join the discussion
Discuss your evidence approach with us
Get a practical walkthrough of how the platform can support clearer, locally relevant assessment of diagnostic AI, medtech, biotech, and pharma products.
Products
Designed to help you maximize the value of your diagnostic, prognostic, or companion diagnostic product.
Medip Analytics offers a cost-effectiveness evaluation service for your diagnostic, prognostic, or companion diagnostic product across any disease area.
Database and analysis of cost data from US hospitals. Search for healthcare costs based on CPT-code.
Our consultancy services are designed to assist companies with all health economic questions. We leverage our scientific expertise and extensive experience to advise you on your health economic strategy.
